NEO R&D to Revenue
Neogenomics Inc · R&D to Revenue
NEO R&D to Revenue
Latest reported5.10%period ending
NEO FY R&D/Revenue (0.00% → 5.10%)
Latest values, visible window
High-resolution chart · PNG
NEO r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.0977% | |
| 4.717% | |
| 4.6158% | |
| 5.9494% | |
| 4.5161% | |
| 1.8515% | |
| 2.0759% | |
| 1.0844% | |
| 1.5134% | |
| 1.9047% | |
| 4.2063% | |
| 3.0884% | |
| 3.671% | |
| 3.8101% | |
| 1.2487% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 49.6454% | |
| 0% | |
| 0% |